Understanding Thrombocytopenic Myelofibrosis (MF) and a Treatment Option
Understanding Thrombocytopenic Myelofibrosis (MF) and a Treatment Option
A panel of three MF experts will discuss their approach to patient identification and treatment goals for patients with myelofibrosis and thrombocytopenia. Additionally, there will be a focus on the efficacy and safety data of a specific MF treatment.
A panel of three MF experts will discuss their approach to patient identification and treatment goals for patients with myelofibrosis and thrombocytopenia. Additionally, there will be a focus on the efficacy and safety data of a specific MF treatment.
Distinguished Faculty:
Distinguished Faculty:
John Mascarenhas, MD
John Mascarenhas, MD
Mount Sinai Medical Center
New York, NY
Mount Sinai Medical Center
New York, NY
Ginna Granroth PA-C, MS
Ginna Granroth PA-C, MS
City of Hope
Phoenix, AZ
City of Hope
Phoenix, AZ
Ashwin Kishtagari, MD
Ashwin Kishtagari, MD
Vanderbilt
Nashville, TN
Vanderbilt
Nashville, TN
REGISTRATION FORM
REGISTRATION FORM
REGISTRATION FORM
Copyright © 2024. All rights reserved.